EFG Asset Management (Americas)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,933
| Closed | -$234K | – | 145 |
|
|
2023
Q3 | $234K | Sell |
1,933
-87
| -4% | -$10.5K | 0.06% | 133 |
|
|
2023
Q2 | $231K | Buy |
2,020
+282
| +16% | +$32.3K | 0.05% | 136 |
|
|
2023
Q1 | $240K | Buy |
1,738
+77
| +5% | +$10.6K | 0.06% | 130 |
|
|
2022
Q4 | $215K | Buy |
+1,661
| New | +$215K | 0.05% | 125 |
|
|
2021
Q1 | – | Sell |
-16,428
| Closed | -$2.8M | – | 150 |
|
|
2020
Q4 | $2.8M | Sell |
16,428
-3,602
| -18% | -$614K | 0.57% | 69 |
|
|
2020
Q3 | $2.81M | Sell |
20,030
-1,783
| -8% | -$250K | 0.63% | 59 |
|
|
2020
Q2 | $3.5M | Sell |
21,813
-2,790
| -11% | -$447K | 0.91% | 45 |
|
|
2020
Q1 | $2.41M | Sell |
24,603
-7,310
| -23% | -$715K | 0.77% | 52 |
|
|
2019
Q4 | $4.12M | Buy |
31,913
+11,812
| +59% | +$1.52M | 1.09% | 32 |
|
|
2019
Q3 | $1.51M | Buy |
20,101
+1,369
| +7% | +$103K | 0.46% | 69 |
|
|
2019
Q2 | $2.85M | Buy |
18,732
+3,631
| +24% | +$552K | 0.81% | 57 |
|
|
2019
Q1 | $1.8M | Buy |
+15,101
| New | +$1.8M | 0.55% | 67 |
|